192 related articles for article (PubMed ID: 32466320)
1. A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome.
Na YJ; Choi KJ; Jung WH; Park SB; Kang S; Ahn JH; Kim KY
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466320
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.
Na YJ; Choi KJ; Park SB; Sung HR; Jung WH; Kim HY; Rhee SD; Kim KY
Apoptosis; 2017 Nov; 22(11):1441-1453. PubMed ID: 28887719
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma.
Choi KJ; Na YJ; Jung WH; Park SB; Kang S; Nam HJ; Ahn JH; Kim KY
Biochem Pharmacol; 2019 Nov; 169():113632. PubMed ID: 31494147
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor via the stimulation of heme oxygenase-1 in LPS-activated mice and J774.1 murine macrophages.
Park SB; Park JS; Jung WH; Kim HY; Kwak HJ; Ahn JH; Choi KJ; Na YJ; Choi S; Dal Rhee S; Kim KY
J Pharmacol Sci; 2016 Aug; 131(4):241-50. PubMed ID: 27523796
[TBL] [Abstract][Full Text] [Related]
6. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
Park SB; Jung WH; Kang NS; Park JS; Bae GH; Kim HY; Rhee SD; Kang SK; Ahn JH; Jeong HG; Kim KY
Eur J Pharmacol; 2013 Dec; 721(1-3):70-9. PubMed ID: 24135201
[TBL] [Abstract][Full Text] [Related]
7. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
[TBL] [Abstract][Full Text] [Related]
8. Carbenoxolone prevents chemical eye ischemia-reperfusion-induced cell death via 11β-hydroxysteroid dehydrogenase type 1 inhibition.
Choi KJ; Na YJ; Park SB; Jung WH; Sung HR; Kim KY
Pharmacol Res; 2017 Sep; 123():62-72. PubMed ID: 28687341
[TBL] [Abstract][Full Text] [Related]
9. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
[TBL] [Abstract][Full Text] [Related]
10. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101.
Hong SP; Han D; Chang KH; Ahn SK
Eur J Pharmacol; 2018 Sep; 835():169-178. PubMed ID: 30096297
[TBL] [Abstract][Full Text] [Related]
11. Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11β-HSD1 inhibitors.
Valverde E; Seira C; McBride A; Binnie M; Luque FJ; Webster SP; Bidon-Chanal A; Vázquez S
Bioorg Med Chem; 2015 Dec; 23(24):7607-17. PubMed ID: 26596711
[TBL] [Abstract][Full Text] [Related]
12. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344).
Park JS; Rhee SD; Kang NS; Jung WH; Kim HY; Kim JH; Kang SK; Cheon HG; Ahn JH; Kim KY
Biochem Pharmacol; 2011 Apr; 81(8):1028-35. PubMed ID: 21315688
[TBL] [Abstract][Full Text] [Related]
13. The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors.
Cheng H; Hoffman J; Le P; Nair SK; Cripps S; Matthews J; Smith C; Yang M; Kupchinsky S; Dress K; Edwards M; Cole B; Walters E; Loh C; Ermolieff J; Fanjul A; Bhat GB; Herrera J; Pauly T; Hosea N; Paderes G; Rejto P
Bioorg Med Chem Lett; 2010 May; 20(9):2897-902. PubMed ID: 20363126
[TBL] [Abstract][Full Text] [Related]
14. 11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes.
Koh EH; Kim AR; Kim H; Kim JH; Park HS; Ko MS; Kim MO; Kim HJ; Kim BJ; Yoo HJ; Kim SJ; Oh JS; Woo CY; Jang JE; Leem J; Cho MH; Lee KU
J Endocrinol; 2015 Jun; 225(3):147-58. PubMed ID: 25869616
[TBL] [Abstract][Full Text] [Related]
15. A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation.
Park JS; Bae SJ; Choi SW; Son YH; Park SB; Rhee SD; Kim HY; Jung WH; Kang SK; Ahn JH; Kim SH; Kim KY
J Mol Endocrinol; 2014 Apr; 52(2):191-202. PubMed ID: 24444497
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA
Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor.
Ye XY; Chen SY; Wu S; Yoon DS; Wang H; Hong Z; O'Connor SP; Li J; Li JJ; Kennedy LJ; Walker SJ; Nayeem A; Sheriff S; Camac DM; Ramamurthy V; Morin PE; Zebo R; Taylor JR; Morgan NN; Ponticiello RP; Harrity T; Apedo A; Golla R; Seethala R; Wang M; Harper TW; Sleczka BG; He B; Kirby M; Leahy DK; Li J; Hanson RL; Guo Z; Li YX; DiMarco JD; Scaringe R; Maxwell B; Moulin F; Barrish JC; Gordon DA; Robl JA
J Med Chem; 2017 Jun; 60(12):4932-4948. PubMed ID: 28537398
[TBL] [Abstract][Full Text] [Related]
18. Novel 11β-HSD1 inhibitors: C-1 versus C-2 substitution and effect of the introduction of an oxygen atom in the adamantane scaffold.
Leiva R; Seira C; McBride A; Binnie M; Luque FJ; Bidon-Chanal A; Webster SP; Vázquez S
Bioorg Med Chem Lett; 2015 Oct; 25(19):4250-3. PubMed ID: 26306982
[TBL] [Abstract][Full Text] [Related]
19. Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
Su X; Halem HA; Thomas MP; Moutrille C; Culler MD; Vicker N; Potter BV
Bioorg Med Chem; 2012 Nov; 20(21):6394-402. PubMed ID: 23040895
[TBL] [Abstract][Full Text] [Related]
20. Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors.
Webster SP; Ward P; Binnie M; Craigie E; McConnell KM; Sooy K; Vinter A; Seckl JR; Walker BR
Bioorg Med Chem Lett; 2007 May; 17(10):2838-43. PubMed ID: 17350260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]